Compare BGS & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BGS | ENTA |
|---|---|---|
| Founded | 1996 | 1995 |
| Country | United States | United States |
| Employees | 86 | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 445.5M | 382.7M |
| IPO Year | 2004 | 2012 |
| Metric | BGS | ENTA |
|---|---|---|
| Price | $3.88 | $13.88 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $4.90 | ★ $20.40 |
| AVG Volume (30 Days) | ★ 2.0M | 187.1K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | ★ 14.34% | N/A |
| EPS Growth | ★ 83.02 | 29.93 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,828,687,000.00 | $102,814,000.00 |
| Revenue This Year | N/A | $7.76 |
| Revenue Next Year | $0.52 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.48 |
| 52 Week Low | $3.67 | $6.44 |
| 52 Week High | $6.38 | $17.15 |
| Indicator | BGS | ENTA |
|---|---|---|
| Relative Strength Index (RSI) | 37.52 | 61.63 |
| Support Level | N/A | $13.19 |
| Resistance Level | $4.67 | $13.97 |
| Average True Range (ATR) | 0.14 | 0.82 |
| MACD | 0.03 | 0.28 |
| Stochastic Oscillator | 34.72 | 92.64 |
B&G Foods Inc manufactures, sells, and distributes a range of branded, shelf-stable, and frozen food and household products across the United States, Canada, and Puerto Rico. Its products include frozen and canned vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. The company's main brands include Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma's, New York Style, B&M, Baker's Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit. It operates in four reportable segments: i) Specialty, the majoriy revenue generating segment, ii) Meals, iii) Frozen & Vegetables, iv) Spices & Flavor Solutions.
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.